An ataxic neuropathy in Nigeria. A clinical, biochemical and electrophysiological study.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D001259:Ataxia / Q000453:epidemiology*; D002648:Child; D002675:Child, Preschool; D003486:Cyanides; D003638:Deafness / Q000150:complications; D004032:Diet; D004576:Electromyography; D005260:Female; D005492:Folic Acid / Q000097:blood; D005684:Gait; D005951:Glucose Tolerance Test; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007866:Leg; D008297:Male; D008875:Middle Aged; D009046:Motor Neurons / Q000503:physiopathology; D009132:Muscles / Q000503:physiopathology; D009422:Nervous System Diseases / Q000453:epidemiology*; D009549:Nigeria; D009748:Nutrition Disorders / Q000150:complications*; D012021:Reflex, Abnormal / Q000150:complications; D012257:Riboflavin Deficiency / Q000150:complications; D012677:Sensation; D012737:Sex Factors; D013861:Thiocyanates / Q000097:blood / Q000652:urine; D014786:Vision Disorders / Q000150:complications; D014805:Vitamin B 12 / Q000097:blood
D003486:Cyanides; D013861:Thiocyanates; D005492:Folic Acid; D014805:Vitamin B 12